Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
9,810,831
-
Share change
-
+1,392,096
-
Total reported value
-
$253,209,742
-
Put/Call ratio
-
229%
-
Price per share
-
$25.81
-
Number of holders
-
83
-
Value change
-
+$36,170,587
-
Number of buys
-
38
-
Number of sells
-
30
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2015
As of 30 Jun 2015,
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,810,831 shares.
The largest 10 holders included
Birchview Capital, LP, CANNELL PETER B & CO INC, VANGUARD GROUP INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., Miura Global Management, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, OBERMEYER WOOD INVESTMENT COUNSEL, LLLP, and Iguana Healthcare Management, LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.